Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
Bayer has announced that the HSE has granted hospital pricing approval for EYLEA® 8mg for eligible adult patients with wet age-related macular degeneration and diabetic macular oedema in Ireland.
Penthrox (methoxyflurane) is now licensed for use in children aged six and over in Ireland, expanding emergency trauma pain relief options in hospital and pre-hospital settings.
Nordic Pharma has announced the European launch of Lacrifill®, a CE-marked canalicular gel designed to enhance tear film preservation in patients with dry eye disease.
PADCEV (enfortumab vedotin) plus Keytruda has demonstrated significant improvements in event-free and overall survival in patients with muscle-invasive bladder cancer, regardless of cisplatin eligibility.
Uniphar has announced the acquisition of Irish health technology provider TouchStore, supporting further digital innovation across medicines supply and dispensing systems.
Teclistamab, an off-the-shelf (ready to use) subcutaneously administered therapy, induced deep and rapid responses in triple-class exposed patients with relapsed and refractory multiple myeloma[1] Johnson & Johnson Innovative…
Teva Pharmaceuticals is pleased to announce the launch of Fingolimod Teva, a generic high tech prescription medication indicated for multiple sclerosis. Fingolimod Teva is available in 0.5 mg…
Teva Pharmaceuticals is pleased to announce the launch of Varenicline Teva, a generic prescription medication indicated for smoking cessation. Varenicline Teva works by targeting nicotine receptors in the…
Clonmel Healthcare are delighted to announce the introduction of Uzpruvo®, the new Ustekinumab biosimilar. Uzpruvo® will be marketed from July 22nd 2024, upon expiry of patent protection of…
You’re all caught up.
